Literature DB >> 8151332

Meta-analysis of adjuvant chemotherapy in gastric cancer: a critical reappraisal.

J P Pignon, M Ducreux, P Rougier.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8151332     DOI： 10.1200/JCO.1994.12.4.877

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  11 in total

1.  Guidelines for the management of oesophageal and gastric cancer.

Authors:  W H Allum; S M Griffin; A Watson; D Colin-Jones
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

2.  Prognostic effects of oral anti-cancer drugs as adjuvant chemotherapy for 2 years after gastric cancer surgery.

Authors:  Toshiro Okuyama; Daisuke Korenaga; Ai Edagawa; Shinji Itoh; Eiji Oki; Hirofumi Kawanaka; Yasuharu Ikeda; Yoshihiro Kakeji; Masahiro Tateishi; Shunichi Tsujitani; Kenji Takenaka; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-01-27       Impact factor: 2.549

Review 3.  Chemotherapy sensitivity and resistance testing: to be "standard" or to be individualized, that is the question.

Authors:  Tetsuro Kubota; Larry Weisenthal
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

4.  Implementation and limitations of meta-analysis of randomized trials from the clinical biostatistician's point of view.

Authors:  Junichi Sakamoto
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

5.  A Pilot Study of Post-Operative Adjuvant Vaccine for Advanced Gastric Cancer.

Authors:  Yoshiyuki Fujiwara; Keijiro Sugimura; Hiroshi Miyata; Takeshi Omori; Hiroyuki Nakano; Chie Mochizuki; Katsuji Shimizu; Hiroaki Saito; Keigo Ashida; Soichiro Honjyo; Yusuke Nakamura; Masahiko Yano
Journal:  Yonago Acta Med       Date:  2017-06-26       Impact factor: 1.641

6.  Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials.

Authors:  Jian-Kun Hu; Zhi-Xin Chen; Zong-Guang Zhou; Bo Zhang; Jing Tian; Jia-Ping Chen; Li Wang; Chao-Hua Wang; Hong-Yan Chen; You-Ping Li
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

Review 7.  UFT (tegafur and uracil) as postoperative adjuvant chemotherapy for solid tumors (carcinoma of the lung, stomach, colon/rectum, and breast): clinical evidence, mechanism of action, and future direction.

Authors:  Fumihiro Tanaka
Journal:  Surg Today       Date:  2007-10-25       Impact factor: 2.549

8.  Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy.

Authors:  Kazumasa Fujitani; Shigeyuki Tamura; Yutaka Kimura; Takeshi Tsuji; Jin Matsuyama; Shohei Iijima; Hiroshi Imamura; Kentaro Inoue; Kenji Kobayashi; Yukinori Kurokawa; Toshio Shimokawa; Toshimasa Tsujinaka; Hiroshi Furukawa
Journal:  Gastric Cancer       Date:  2013-06-05       Impact factor: 7.370

Review 9.  What make differences in the outcome of adjuvant treatments for resected gastric cancer?

Authors:  Toshifusa Nakajima; Masashi Fujii
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

10.  Five-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy (OGSG1002).

Authors:  Kazumasa Fujitani; Shigeyuki Tamura; Yutaka Kimura; Jin Matsuyama; Hiroshi Imamura; Kazuyoshi Yamamoto; Junya Fujita; Shohei Iijima; Shugo Ueda; Yukinori Kurokawa; Toshio Shimokawa; Taroh Satoh
Journal:  Gastric Cancer       Date:  2019-10-30       Impact factor: 7.370
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.